Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2011-6-28
pubmed:abstractText
Bardet-Biedl syndrome (BBS) is a multisystem disorder caused by ciliary defects. To date, mutations in 15 genes have been associated with the disease and BBS1 is most frequently affected in patients with BBS. The use of homozygosity mapping in a large consanguineous family allowed us to identify the splice donor site (SD) mutation c.479G>A in exon 5 of BBS1. Clinically affected family members show symptoms of retinitis pigmentosa (RP) but lack other primary features that would clearly support the diagnosis of BBS. In agreement with this exceptionally mild BBS1-associated phenotype, we did not detect obvious ciliary defects in patient-derived cells. SDs are bound by the U1 small nuclear RNA (U1), a process that initiates exon recognition during splicing. The mutation described herein interferes with U1 binding and induces aberrant splicing of BBS1. For a gene therapeutic approach, we have adapted the sequence of U1 to increase its complementarity to the mutated SD. Lentiviral treatment of patient-derived fibroblasts with the adapted U1 partially corrected aberrant splicing of endogenously expressed BBS1 transcripts. This therapeutic effect was dose-dependent. Our results show that the adaptation of U1 can correct pathogenic effects of splice donor site mutations and suggest a high potential for gene therapy.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1098-1004
pubmed:author
pubmed:copyrightInfo
© 2011 Wiley-Liss, Inc.
pubmed:issnType
Electronic
pubmed:volume
32
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
815-24
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:21520335-Adult, pubmed-meshheading:21520335-Bardet-Biedl Syndrome, pubmed-meshheading:21520335-Cells, Cultured, pubmed-meshheading:21520335-Exons, pubmed-meshheading:21520335-Female, pubmed-meshheading:21520335-Fibroblasts, pubmed-meshheading:21520335-Gene Expression, pubmed-meshheading:21520335-Gene Therapy, pubmed-meshheading:21520335-Genetic Linkage, pubmed-meshheading:21520335-Genetic Vectors, pubmed-meshheading:21520335-Humans, pubmed-meshheading:21520335-Lentivirus, pubmed-meshheading:21520335-Male, pubmed-meshheading:21520335-Microtubule-Associated Proteins, pubmed-meshheading:21520335-Middle Aged, pubmed-meshheading:21520335-Mutation, pubmed-meshheading:21520335-Pedigree, pubmed-meshheading:21520335-Protein Binding, pubmed-meshheading:21520335-Proteins, pubmed-meshheading:21520335-RNA, Small Nuclear, pubmed-meshheading:21520335-RNA Splice Sites, pubmed-meshheading:21520335-Retinitis Pigmentosa
pubmed:year
2011
pubmed:articleTitle
U1 snRNA-mediated gene therapeutic correction of splice defects caused by an exceptionally mild BBS mutation.
pubmed:affiliation
University of Zurich, Institute of Medical Molecular Genetics, Schorenstrasse 16, Schwerzenbach, Switzerland.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't